![Logo](/assets/logo-d3f1fdf60522f0983e71f9fcc720cb7da5b55c0b748ed5bded3d2fbf81387bf0.png)
CORD-19:cb16d307afaecebd683e6d74c8b501ed54b0c9a4 / 27599-27800
Annnotations
{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/cb16d307afaecebd683e6d74c8b501ed54b0c9a4","sourcedb":"CORD-19","sourceid":"cb16d307afaecebd683e6d74c8b501ed54b0c9a4","text":"The MTT assay outcomes implied that HL exhibited the better cytotoxic activity against HePG2 and PC3 cell lines than 5-Fluorouracil with IC 50 values being 5.69 and 6.80 mg/mL, respectively (Table 6) .","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T164","span":{"begin":0,"end":201},"obj":"Sentence"},{"id":"T30808","span":{"begin":0,"end":201},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T164","pred":"source","obj":"CORD-19-Sentences"},{"subj":"T30808","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T26","span":{"begin":4,"end":7},"obj":"Disease"},{"id":"T27","span":{"begin":97,"end":100},"obj":"Disease"},{"id":"T21594","span":{"begin":4,"end":7},"obj":"Disease"},{"id":"T33287","span":{"begin":97,"end":100},"obj":"Disease"}],"attributes":[{"id":"A26","pred":"mondo_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/MONDO_0016757"},{"id":"A27","pred":"mondo_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/MONDO_0014324"},{"id":"A71414","pred":"mondo_id","subj":"T21594","obj":"http://purl.obolibrary.org/obo/MONDO_0016757"},{"id":"A23017","pred":"mondo_id","subj":"T33287","obj":"http://purl.obolibrary.org/obo/MONDO_0014324"},{"subj":"T26","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T27","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T21594","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T33287","pred":"source","obj":"CORD-19-PD-MONDO"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T164","span":{"begin":0,"end":201},"obj":"Sentence"}],"attributes":[{"subj":"T164","pred":"source","obj":"CORD-19_Custom_license_subset"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#93d1ec","default":true},{"id":"CORD-19-PD-MONDO","color":"#ecec93"},{"id":"CORD-19_Custom_license_subset","color":"#d293ec"}]}]}}